Zobrazeno 1 - 10
of 516
pro vyhledávání: '"Byung-wan Lee"'
Autor:
Jun Sung Moon, Shinae Kang, Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Ji A Seo, Mee Kyoung Kim, Jeong Hyun Lim, Yoon Ju Song, Ye Seul Yang, Jae Hyeon Kim, You-Bin Lee, Junghyun Noh, Kyu Yeon Hur, Jong Suk Park, Sang Youl Rhee, Hae Jin Kim, Hyun Min Kim, Jung Hae Ko, Nam Hoon Kim, Chong Hwa Kim, Jeeyun Ahn, Tae Jung Oh, Soo-Kyung Kim, Jaehyun Kim, Eugene Han, Sang-Man Jin, Jaehyun Bae, Eonju Jeon, Ji Min Kim, Seon Mee Kang, Jung Hwan Park, Jae-Seung Yun, Bong-Soo Cha, Min Kyong Moon, Byung-Wan Lee
Publikováno v:
Diabetes & Metabolism Journal, Vol 48, Iss 4, Pp 546-708 (2024)
Externí odkaz:
https://doaj.org/article/1ca1a0c775dc4613bbda82213581a6e5
Publikováno v:
Gut and Liver, Vol 18, Iss 3, Pp 509-519 (2024)
Background/Aims: Reports on the association between sarcopenic visceral obesity and non-alcoholic fatty liver disease (NAFLD)-associated morbidities remain scarce. We investigated the association between sarcopenia and visceral obesity, and the influ
Externí odkaz:
https://doaj.org/article/455dc4dceb1b4ecf9b2dba4484ca9454
Autor:
Sejeong Lee, Jaehyun Bae, Seung Up Kim, Minyoung Lee, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2024)
AimHepatic ketogenesis is a key metabolic pathway that regulates energy homeostasis. Some related controversies exist regarding the pathogenesis of metabolic-associated fatty liver disease (MAFLD). We aimed to investigate whether intact ketogenic cap
Externí odkaz:
https://doaj.org/article/2869af4844d34245ad8fc77ff0a1329b
Autor:
Eugene Han, Yong-ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Seung Up Kim
Publikováno v:
Gut and Liver, Vol 16, Iss 5, Pp 786-797 (2022)
Background/Aims: Metabolic dysfunction associated fatty liver disease (MAFLD) has recently been introduced to compensate for the conventional concept of nonalcoholic fatty liver disease (NAFLD). We explored whether fibrotic burden determines the risk
Externí odkaz:
https://doaj.org/article/15bdfa0e836d4ce8aeb3e9f4887ed1b1
Autor:
Jong Ha Baek, Ye Seul Yang, Seung-Hyun Ko, Kyung Do Han, Jae Hyeon Kim, Min Kyong Moon, Jong Suk Park, Byung-Wan Lee, Tae Jung Oh, Suk Chon, Jong Han Choi, Kyu Yeon Hur
Publikováno v:
Diabetes & Metabolism Journal, Vol 46, Iss 5, Pp 701-712 (2022)
Background To evaluate prescription trends and clinical factors of the sodium-glucose cotransporter 2 inhibitors (SGLT2i) use according to the presence of atherosclerotic cardiovascular disease (ASCVD) or heart failure (HF) in Korean patients with ty
Externí odkaz:
https://doaj.org/article/87ddde7c96524004afd813e104cb4206
Autor:
Gian Paolo Fadini, Giovanni Targher, Masahide Hamaguchi, Herbert Tilg, Seung Up Kim, Dan-Qin Sun, Xuhong Hou, Jianghua Zhou, Christopher D Byrne, Byung-wan Lee, Masato Furuhashi, Ning-Jian Wang
Publikováno v:
eGastroenterology, Vol 1, Iss 1 (2023)
Background and aim Metabolic dysfunction-associated fatty liver disease (MAFLD) is an alternative description and classification of non-alcoholic fatty liver disease (NAFLD) that may have better utility than NAFLD in clinical practice. We performed a
Externí odkaz:
https://doaj.org/article/63a6f9538f874914ae97401e9544541f
Autor:
Jaehyun Bae, Ji Young Lee, Eugene Shin, Minyoung Lee, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract The α-glucosidase inhibitor (α-GI) delays the intestinal absorption of glucose, which reduces postprandial hepatic glucose intake. This mechanism is considered to be effective in treating non-alcoholic fatty liver disease (NAFLD). Here, we
Externí odkaz:
https://doaj.org/article/d836661f375c45c99aff1ad618050d41
Autor:
Ji Young Lee, Minyoung Lee, Dong-Hee Lee, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
Publikováno v:
Endocrinology and Metabolism, Vol 37, Iss 4, Pp 684-697 (2022)
Background Muscle atrophy is caused by an imbalance between muscle growth and wasting. Delta-like 1 homolog (DLK1), a protein that modulates adipogenesis and muscle development, is a crucial regulator of myogenic programming. Thus, we investigated th
Externí odkaz:
https://doaj.org/article/6ad97cf64a0a4182be3acc35160ecce8
Publikováno v:
Endocrinology and Metabolism, Vol 37, Iss 3, Pp 466-474 (2022)
Background Diabetes is a leading cause of death that is responsible for 1.6 million annual deaths worldwide. However, the life expectancy and age at death of people with diabetes have been a matter of debate. Methods The National Health Insurance Ser
Externí odkaz:
https://doaj.org/article/d9b1e2ae489a4e3aabb309f5f6f4ff2c
Autor:
Yuna Kim, Eugene Han, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Mi Kyung Kim, Hye Soon Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Yong-ho Lee, Seung Up Kim
Publikováno v:
Gut and Liver, Vol 16, Iss 2, Pp 290-299 (2022)
Background/Aims: Nonalcoholic fatty liver disease (NAFLD) and obesity are independently associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD), the leading cause of mortality in patients with NAFLD. Many NAFLD patients a
Externí odkaz:
https://doaj.org/article/7e7c8e522c1243eda3e71f4797ed1920